Amid backlash, FDA changes course over shortage of weight-loss drugs
Washington Post
The FDA said Eli Lilly’s weight-loss drugs were no longer in shortage on Oct. 2, preventing pharmacies from making cheaper versions. After an outcry, it’s reconsidering.
https://www.washingtonpost.com/business/2024/10/19/weight-loss-drugs-fda-eli-lilly/